Income Statement Clinitech Laboratory Limited

Stocks

544220

INE0QMR01015

Healthcare Facilities & Services

Market Closed - Bombay S.E. 14:02:28 07/10/2026 +04			5-day change	1st Jan Change
32.00 ^INR	-4.90%		-8.83%	-23.99%

05-28	Clinitech Laboratory Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
02-17	Analog IVD Solutions Private Limited announced that it has received INR 0.1 million in funding from Clinitech Laboratory Limited and other investors	CI

c4421384db7cbe74bbbd97eb43cab6.nRmngD-x3vorHS2euOw_5AK7VrZaB8M7kjmXU7oHaJY.6CvytAf1mKN5Ll_R1aNHvWeCG4YLYKcW13_CZd9wIOfvIOvoetmQkRp6Tg

Published financial data: CLINITECH LABORATORY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	63.84M	63.48M	64.03M	82.35M	94.91M
Total Revenues	63.84M	63.48M	64.03M	82.35M	94.91M
Cost of Goods Sold, Total	18.18M	14.14M	13.78M	18.81M	26.3M
Gross Profit	45.66M	49.33M	50.25M	63.54M	68.61M
Selling General & Admin Expenses, Total	17.79M	20.32M	22.88M	29.23M	35.91M
Depreciation & Amortization - (IS)	3.81M	4.46M	4.39M	4.5M	5.1M
Other Operating Expenses	17.18M	15.49M	17.43M	25.99M	22.52M
Other Operating Expenses, Total	38.78M	40.27M	44.7M	59.72M	63.53M
Operating Income	6.88M	9.06M	5.54M	3.82M	5.08M
Interest Expense, Total	-416K	-582K	-734K	-429K	-325K
Interest And Investment Income	57K	76K	1K	1.3M	1.23M
Net Interest Expenses	-359K	-506K	-733K	868K	904K
Income (Loss) On Equity Invest.	109K	44K	-	-	-
Other Non Operating Income (Expenses)	395K	39K	134K	177K	-22K
EBT, Excl. Unusual Items	7.02M	8.64M	4.94M	4.87M	5.96M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-1K	-	107K	680K	-
EBT, Incl. Unusual Items	7.02M	8.64M	5.05M	5.55M	5.96M
Income Tax Expense	1.9M	2.51M	1.34M	1.6M	1.81M
Earnings From Continuing Operations	5.13M	6.13M	3.71M	3.95M	4.15M
Net Income to Company	5.13M	6.13M	3.71M	3.95M	4.15M
Minority Interest	-	-	-	-	31K
Net Income - (IS)	5.13M	6.13M	3.71M	3.95M	4.18M
Net Income to Common Incl Extra Items	5.13M	6.13M	3.71M	3.95M	4.18M
Net Income to Common Excl. Extra Items	5.13M	6.13M	3.71M	3.95M	4.18M
Per Share Items
Net EPS - Basic	3.42	4.09	2.37	1.9	1.83
Basic EPS - Continuing Operations	3.42	4.09	2.37	1.9	1.83
Basic Weighted Average Shares Outstanding	1.5M	1.5M	1.57M	2.08M	2.28M
Net EPS - Diluted	3.42	4.09	2.37	1.9	1.83
Diluted EPS - Continuing Operations	3.42	4.09	2.37	1.9	1.83
Diluted Weighted Average Shares Outstanding	1.5M	1.5M	1.57M	2.08M	2.28M
Normalized Basic EPS	2.93	3.6	1.97	1.46	1.65
Normalized Diluted EPS	2.93	3.6	1.97	1.46	1.65
Supplemental Items
EBITDA	10.69M	13.52M	9.93M	8.32M	10.16M
EBITA	6.88M	9.09M	5.6M	3.82M	5.08M
EBIT	6.88M	9.06M	5.54M	3.82M	5.08M
EBITDAR	-	-	-	-	14.27M
Total Revenues (As Reported)	64.57M	63.63M	64.39M	84.63M	96.79M
Effective Tax Rate - (Ratio)	27	29.01	26.52	28.83	30.41
Total Current Taxes	2.09M	3M	1.44M	1.6M	2.14M
Total Deferred Taxes	-194K	-494K	-97K	4K	-327K
Normalized Net Income	4.39M	5.4M	3.09M	3.04M	3.76M
Interest on Long-Term Debt	-	-	-	-	693K
Non-Cash Pension Expense	-	-	-	155K	-
Supplemental Operating Expense Items
Advertising Expense	-	-	-	616K	961K
Selling and Marketing Expenses	-	-	-	616K	961K
Net Rental Expense, Total	-	-	-	-	4.11M
Maintenance & Repair Expenses, Total	224K	253K	429K	487K	519K

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	1.04M	7.84M	7.01M	30.75M	21.12M
Total Cash And Short Term Investments	1.04M	7.84M	7.01M	30.75M	21.12M
Accounts Receivable, Total	3.64M	4.89M	5.98M	15.41M	18.55M
Other Receivables	-	-	-	538K	9K
Total Receivables	3.64M	4.89M	5.98M	15.95M	18.56M
Inventory	1.56M	1.41M	2.84M	5.29M	7.3M
Prepaid Expenses	187K	126K	303K	230K	520K
Other Current Assets, Total	7.41M	5.38M	10.97M	21.17M	26.24M
Total Current Assets	13.84M	19.64M	27.11M	73.39M	73.75M
Gross Property Plant And Equipment	38.78M	41.5M	53.52M	52.68M	60.56M
Accumulated Depreciation	-18.25M	-22.68M	-27.02M	-31.49M	-36.57M
Net Property Plant And Equipment	20.53M	18.82M	26.51M	21.19M	23.99M
Long-term Investments	1.4M	1.28M	729K	729K	1.65M
Other Intangibles, Total	28K	78K	64K	10.15M	10.31M
Deferred Tax Assets Long-Term	1.08M	1.57M	1.67M	1.66M	1.99M
Deferred Charges Long-Term	-	-	-	-	105K
Other Long-Term Assets, Total	-	18.94M	-	-	-
Total Assets	36.87M	60.33M	56.08M	107M	112M
Liabilities
Accounts Payable, Total	5.19M	4M	3.46M	6.28M	4.84M
Accrued Expenses, Total	1.88M	4.02M	3.85M	6.36M	3.41M
Short-term Borrowings	4.57M	6.71M	5.77M	-	-
Current Portion of Long-Term Debt	717K	763K	522K	-	-
Current Income Taxes Payable	-	-	1.44M	3.02M	1.62M
Other Current Liabilities	1.26M	2.08M	1.28M	1.17M	1.48M
Total Current Liabilities	13.62M	17.57M	16.32M	16.83M	11.35M
Long-Term Debt	3.57M	2.82M	2.34M	-	5.38M
Unearned Revenue Non Current	-	14.9M	-	-	-
Pension & Other Post Retirement Benefits	1.21M	1.23M	1.94M	1.99M	2.53M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	18.39M	36.52M	20.6M	18.82M	19.26M
Common Stock, Total	15M	15M	16.8M	22.82M	22.82M
Additional Paid In Capital	-	-	5.04M	47.89M	47.89M
Retained Earnings	3.48M	8.81M	13.64M	17.59M	21.77M
Total Common Equity	18.48M	23.81M	35.48M	88.3M	92.48M
Minority Interest	-	-	-	-	49K
Total Equity	18.48M	23.81M	35.48M	88.3M	92.53M
Total Liabilities And Equity	36.87M	60.33M	56.08M	107M	112M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.5M	1.5M	2.28M	2.28M	2.28M
ECS Total Common Shares Outstanding	1.5M	1.5M	2.28M	2.28M	2.28M
Book Value / Share	12.32	15.87	15.55	38.69	40.52
Tangible Book Value	18.45M	23.73M	35.42M	78.15M	82.17M
Tangible Book Value Per Share	12.3	15.82	15.52	34.24	36
Total Debt	8.86M	10.29M	8.63M	0	5.38M
Net Debt	7.82M	2.46M	1.62M	-30.75M	-15.75M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	641K	-
Debt Equivalent Oper. Leases	-	-	-	-	32.9M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	49K
Account Code - Inventory Valuation	-	3	3	3	3
Inventories - Finished Goods, Total	1.56M	1.41M	2.84M	5.29M	7.3M
Machinery, Total	34.74M	35.9M	44.08M	52.68M	58M
Full Time Employees	-	-	85	148	162

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	5.13M	6.13M	3.71M	3.95M	4.18M
Depreciation & Amortization - CF	3.81M	4.43M	4.34M	4.5M	5.08M
Amortization of Goodwill and Intangible Assets - (CF)	2K	31K	55K	-	-
Depreciation & Amortization, Total	3.81M	4.46M	4.39M	4.5M	5.08M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	23K
(Gain) Loss From Sale Of Asset	-	-	-	-680K	-
Other Operating Activities, Total	-907K	-882K	1.39M	-864K	-1.26M
Change In Accounts Receivable	1.94M	-1.25M	-1.09M	-9.43M	-3.14M
Change In Inventories	-668K	146K	-1.43M	-2.44M	-2.02M
Change In Accounts Payable	589K	-1.19M	-534K	2.82M	-2.71M
Change in Other Net Operating Assets	-331K	5.06M	-5.31M	-6.63M	-8.08M
Cash from Operations	9.56M	12.48M	1.12M	-8.79M	-7.93M
Capital Expenditure	-15.14M	-2.8M	-12.06M	-11.65M	-8.26M
Sale of Property, Plant, and Equipment	-	-	-	3.06M	200K
Investment in Marketable and Equity Securities, Total	-488K	-18.82M	19.49M	-	-
Other Investing Activities, Total	969K	15.09M	-13.83M	1.3M	1.23M
Cash from Investing	-14.66M	-6.53M	-6.4M	-7.29M	-6.83M
Short Term Debt Issued, Total	4.72M	2.18M	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	5.38M
Total Debt Issued	4.72M	2.18M	-	-	5.38M
Short Term Debt Repaid, Total	-	-	-1.18M	-5.77M	-
Long-Term Debt Repaid, Total	-1.23M	-750K	-484K	-2.86M	-
Total Debt Repaid	-1.23M	-750K	-1.66M	-8.63M	-
Issuance of Common Stock	-	-	6.84M	48.88M	80K
Other Financing Activities, Total	-562K	-574K	-724K	-429K	-325K
Cash from Financing	2.93M	856K	4.46M	39.82M	5.13M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-1K
Net Change in Cash	-2.17M	6.8M	-819K	23.74M	-9.63M
Supplemental Items
Cash Interest Paid	415K	574K	724K	429K	325K
Cash Income Tax Paid (Refund)	2.09M	3M	1.44M	1.6M	2.14M
Levered Free Cash Flow	-5.76M	9.72M	-13.03M	-20.76M	-15.65M
Unlevered Free Cash Flow	-5.5M	10.09M	-12.58M	-20.49M	-15.45M
Change In Net Working Capital	-1.53M	-2.76M	8.37M	15.73M	15.47M
Net Debt Issued / Repaid	3.49M	1.43M	-1.66M	-8.63M	5.38M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	13.39	11.65	5.95	2.93	2.88
Return on Total Capital	18.44	18.43	8.86	3.61	3.41
Return On Equity %	31.66	29	12.52	6.38	4.59
Return on Common Equity	31.66	29	12.52	6.38	4.62
Margin Analysis
Gross Profit Margin %	71.52	77.72	78.47	77.15	72.29
SG&A Margin	27.86	32.01	35.73	35.5	37.83
EBITDA Margin %	16.74	21.3	15.51	10.1	10.7
EBITA Margin %	10.78	14.32	8.74	4.64	5.35
EBIT Margin %	10.77	14.27	8.66	4.64	5.35
Income From Continuing Operations Margin %	8.03	9.66	5.8	4.79	4.37
Net Income Margin %	8.03	9.66	5.8	4.79	4.4
Net Avail. For Common Margin %	8.03	9.66	5.8	4.79	4.4
Normalized Net Income Margin	6.88	8.5	4.83	3.69	3.96
Levered Free Cash Flow Margin	-9.02	15.32	-20.36	-25.21	-16.49
Unlevered Free Cash Flow Margin	-8.61	15.89	-19.64	-24.88	-16.28
Asset Turnover
Asset Turnover	1.99	1.31	1.1	1.01	0.86
Fixed Assets Turnover	4.29	3.23	2.83	4.3	4.2
Receivables Turnover (Average Receivables)	13.84	14.88	11.78	7.7	5.59
Inventory Turnover (Average Inventory)	14.84	9.52	6.48	4.63	4.18
Short Term Liquidity
Current Ratio	1.02	1.12	1.66	4.36	6.5
Quick Ratio	0.34	0.72	0.8	2.77	3.5
Operating Cash Flow to Current Liabilities	0.7	0.71	0.07	-0.52	-0.7
Days Sales Outstanding (Average Receivables)	26.37	24.53	31.07	47.42	65.29
Days Outstanding Inventory (Average Inventory)	24.59	38.35	56.48	78.85	87.37
Average Days Payable Outstanding	94.73	119.71	89.7	83.6	79.82
Cash Conversion Cycle (Average Days)	-43.77	-56.83	-2.15	42.67	72.85
Long Term Solvency
Total Debt/Equity	47.95	43.22	24.33	-	5.81
Total Debt / Total Capital	32.41	30.18	19.57	-	5.49
LT Debt/Equity	19.32	11.85	6.59	-	5.81
Long-Term Debt / Total Capital	13.06	8.27	5.3	-	5.49
Total Liabilities / Total Assets	49.88	60.54	36.73	17.57	17.22
EBIT / Interest Expense	16.53	15.57	7.55	8.91	15.63
EBITDA / Interest Expense	25.69	23.23	13.53	19.39	31.26
(EBITDA - Capex) / Interest Expense	-10.7	18.42	-2.9	-7.76	5.85
Total Debt / EBITDA	0.83	0.76	0.87	-	0.53
Net Debt / EBITDA	0.73	0.18	0.16	-3.7	-1.55
Total Debt / (EBITDA - Capex)	-1.99	0.96	-4.05	-	2.83
Net Debt / (EBITDA - Capex)	-1.76	0.23	-0.76	9.24	-8.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	40.19	-0.58	0.87	28.61	15.26
Gross Profit, 1 Yr. Growth %	40.73	8.04	1.85	26.45	7.99
EBITDA, 1 Yr. Growth %	29.65	26.5	-26.51	-16.39	18.22
EBITA, 1 Yr. Growth %	18.6	32.14	-38.41	-31.95	23.25
EBIT, 1 Yr. Growth %	18.81	31.72	-38.81	-31.95	23.25
Earnings From Cont. Operations, 1 Yr. Growth %	27.39	19.61	-39.46	6.33	5.09
Net Income, 1 Yr. Growth %	27.39	19.61	-39.46	6.33	5.88
Normalized Net Income, 1 Yr. Growth %	36.24	22.98	-42.75	-1.6	23.5
Diluted EPS Before Extra, 1 Yr. Growth %	27.39	19.61	-42.03	-19.98	-3.49
Accounts Receivable, 1 Yr. Growth %	-34.75	34.2	22.38	157.63	20.36
Inventory, 1 Yr. Growth %	74.97	-9.36	101.06	86.1	38.17
Net Property, Plant and Equip., 1 Yr. Growth %	123.16	-8.35	40.87	24.15	13.18
Total Assets, 1 Yr. Growth %	34.91	63.62	-7.05	91.02	3.12
Tangible Book Value, 1 Yr. Growth %	32.99	28.6	49.25	200.8	5.14
Common Equity, 1 Yr. Growth %	32.93	28.82	49.03	148.87	4.73
Cash From Operations, 1 Yr. Growth %	154.04	30.53	-90.98	-31.43	-9.8
Capital Expenditures, 1 Yr. Growth %	700.9	-81.52	331.36	-3.47	-29.09
Levered Free Cash Flow, 1 Yr. Growth %	-	-268.91	-234.04	59.84	-23.89
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-283.52	-224.66	63.47	-23.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	18.06	0.15	13.9	21.75
Gross Profit, 2 Yr. CAGR %	-	23.31	4.9	13.49	16.85
EBITDA, 2 Yr. CAGR %	-	28.07	-3.58	-21.55	1.05
EBITA, 2 Yr. CAGR %	-	25.19	-9.79	-35.17	-4.89
EBIT, 2 Yr. CAGR %	-	25.1	-10.22	-35.06	-4.89
Earnings From Cont. Operations, 2 Yr. CAGR %	-	23.43	-14.9	-19.76	5.71
Net Income, 2 Yr. CAGR %	-	23.43	-14.9	-19.76	6.1
Normalized Net Income, 2 Yr. CAGR %	-	29.44	-16.09	-24.94	10.25
Diluted EPS Before Extra, 2 Yr. CAGR %	-	23.43	-16.73	-31.89	-12.12
Accounts Receivable, 2 Yr. CAGR %	-	-6.42	28.15	77.56	76.07
Inventory, 2 Yr. CAGR %	-	25.93	34.99	93.43	60.35
Net Property, Plant and Equip., 2 Yr. CAGR %	-	43.01	13.62	6.13	18.54
Total Assets, 2 Yr. CAGR %	-	48.57	23.32	33.25	41.19
Tangible Book Value, 2 Yr. CAGR %	-	30.78	38.54	81.48	77.84
Common Equity, 2 Yr. CAGR %	-	30.86	38.56	92.59	61.45
Cash From Operations, 2 Yr. CAGR %	-	82.1	-65.7	-16.06	-21.35
Capital Expenditures, 2 Yr. CAGR %	-	21.65	-10.72	104.05	-17.27
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	50.47	46.1	9.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	51.25	42.51	11.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	12.03	8.86	14.35
Gross Profit, 3 Yr. CAGR %	-	-	15.7	11.64	11.62
EBITDA, 3 Yr. CAGR %	-	-	6.42	-8.01	-9.08
EBITA, 3 Yr. CAGR %	-	-	-1.17	-17.8	-17.64
EBIT, 3 Yr. CAGR %	-	-	-1.43	-17.79	-17.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-2.65	-8.34	-12.21
Net Income, 3 Yr. CAGR %	-	-	-2.65	-8.34	-11.99
Normalized Net Income, 3 Yr. CAGR %	-	-	-1.38	-11.51	-11.38
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-4.05	-17.83	-23.5
Accounts Receivable, 3 Yr. CAGR %	-	-	2.33	61.74	55.96
Inventory, 3 Yr. CAGR %	-	-	47.19	50.24	72.91
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	42.29	1.06	8.43
Total Assets, 3 Yr. CAGR %	-	-	27.07	42.69	22.82
Tangible Book Value, 3 Yr. CAGR %	-	-	36.66	61.79	51.29
Common Equity, 3 Yr. CAGR %	-	-	36.65	68.43	57.2
Cash From Operations, 3 Yr. CAGR %	-	-	-33.13	-2.77	-14.02
Capital Expenditures, 3 Yr. CAGR %	-	-	85.5	-8.37	43.46
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	53.34	17.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	55.04	15.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	15.82
Gross Profit, 5 Yr. CAGR %	-	-	-	-	16.16
EBITDA, 5 Yr. CAGR %	-	-	-	-	4.27
EBITA, 5 Yr. CAGR %	-	-	-	-	-2.62
EBIT, 5 Yr. CAGR %	-	-	-	-	-2.58
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	0.61
Net Income, 5 Yr. CAGR %	-	-	-	-	0.76
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	3.12
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-7.36
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	27.14
Inventory, 5 Yr. CAGR %	-	-	-	-	52.32
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	21.13
Total Assets, 5 Yr. CAGR %	-	-	-	-	32.54
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	42.72
Common Equity, 5 Yr. CAGR %	-	-	-	-	46.08
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	16.07
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	34.3